Is Phenixfin Stock a Good Investment?
Phenixfin Investment Advice | PFX |
- Examine Phenixfin's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Phenixfin's leadership team and their track record. Good management can help Phenixfin navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Trading space and any emerging trends that could impact Phenixfin's business and its evolving consumer preferences.
- Compare Phenixfin's performance and market position to its competitors. Analyze how Phenixfin is positioned in terms of product offerings, innovation, and market share.
- Check if Phenixfin pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Phenixfin's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Phenixfin stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Phenixfin is a good investment.
Sell | Buy |
Strong Buy
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Phenixfin Stock
Researching Phenixfin's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Phenixfin recorded earning per share (EPS) of 8.16. The entity last dividend was issued on the 14th of February 2025. The firm had 1:20 split on the 27th of July 2020.
To determine if Phenixfin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Phenixfin's research are outlined below:
| About 21.0% of the company outstanding shares are owned by corporate insiders | |
| On 18th of February 2025 Phenixfin paid $ 1.43 per share dividend to its current shareholders |
Phenixfin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Phenixfin. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Phenixfin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Phenixfin's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 109.09 M.Phenixfin's profitablity analysis
The company has Net Profit Margin of 0.73 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.67 %, which entails that for every 100 dollars of revenue, it generated $0.67 of operating income.Determining Phenixfin's profitability involves analyzing its financial statements and using various financial metrics to determine if Phenixfin is a good buy. For example, gross profit margin measures Phenixfin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Phenixfin's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Phenixfin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phenixfin. Check Phenixfin's Beneish M Score to see the likelihood of Phenixfin's management manipulating its earnings.
Basic technical analysis of Phenixfin Stock
As of the 20th of March, Phenixfin holds the Coefficient Of Variation of 752.13, semi deviation of 0.9012, and Risk Adjusted Performance of 0.1218. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phenixfin, as well as the relationship between them.Phenixfin's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phenixfin insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phenixfin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phenixfin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Phenixfin's Outstanding Corporate Bonds
Phenixfin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Phenixfin uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Phenixfin bonds can be classified according to their maturity, which is the date when Phenixfin has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Phenixfin's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Phenixfin's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1218 | |||
| Market Risk Adjusted Performance | 1.13 | |||
| Mean Deviation | 1.1 | |||
| Semi Deviation | 0.9012 | |||
| Downside Deviation | 1.19 | |||
| Coefficient Of Variation | 752.13 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.07 | |||
| Information Ratio | 0.178 | |||
| Jensen Alpha | 0.1935 | |||
| Total Risk Alpha | 0.3028 | |||
| Sortino Ratio | 0.2156 | |||
| Treynor Ratio | 1.12 | |||
| Maximum Drawdown | 5.78 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 3.42 | |||
| Downside Variance | 1.41 | |||
| Semi Variance | 0.8122 | |||
| Expected Short fall | (1.48) | |||
| Skewness | 0.7196 | |||
| Kurtosis | 0.1863 |
| Risk Adjusted Performance | 0.1218 | |||
| Market Risk Adjusted Performance | 1.13 | |||
| Mean Deviation | 1.1 | |||
| Semi Deviation | 0.9012 | |||
| Downside Deviation | 1.19 | |||
| Coefficient Of Variation | 752.13 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.07 | |||
| Information Ratio | 0.178 | |||
| Jensen Alpha | 0.1935 | |||
| Total Risk Alpha | 0.3028 | |||
| Sortino Ratio | 0.2156 | |||
| Treynor Ratio | 1.12 | |||
| Maximum Drawdown | 5.78 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 3.42 | |||
| Downside Variance | 1.41 | |||
| Semi Variance | 0.8122 | |||
| Expected Short fall | (1.48) | |||
| Skewness | 0.7196 | |||
| Kurtosis | 0.1863 |
Consider Phenixfin's intraday indicators
Phenixfin intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Phenixfin stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 53.69 | |||
| Day Typical Price | 53.69 | |||
| Price Action Indicator | 0.15 | |||
| Period Momentum Indicator | 0.31 | |||
| Relative Strength Index | 60.76 |
Phenixfin Stock media impact
Far too much social signal, news, headlines, and media speculation about Phenixfin that are available to investors today. That information is available publicly through Phenixfin media outlets and privately through word of mouth or via Phenixfin internal channels. However, regardless of the origin, that massive amount of Phenixfin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phenixfin news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phenixfin relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phenixfin's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phenixfin alpha.
Phenixfin Corporate Management
| Ryan Phalen | Managing Director | Profile | |
| Gerald Cummins | Chief Officer | Profile | |
| Benjamin Tilewick | Senior Analyst | Profile | |
| Chris Cannellos | Controller | Profile | |
| Ellida CPA | Chief Officer | Profile | |
| Therese Dyman | Controller | Profile |
Additional Tools for Phenixfin Stock Analysis
When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.